Joel Francis Habener, M.D.
This page shows the publications co-authored by Joel Habener and Gordon Weir.
Glucagonlike peptide I (7-37) actions on endocrine pancreas. Diabetes. 1989 Mar; 38(3):338-42.
35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999. Diabetologia. 1999 Aug; 42(Suppl 1):A1-A330.
Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. J Clin Invest. 1998 Jun 01; 101(11):2528-39.
Reduced insulin, GLUT2, and IDX-1 in beta-cells after partial pancreatectomy. Diabetes. 1997 Feb; 46(2):258-64.
Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets. Endocrinology. 1996 Nov; 137(11):5119-25.
Glucagon-like peptide-I-(7-37) suppresses hyperglycemia in rats. Metabolism. 1993 Jan; 42(1):1-6.
Glucagon-like peptide-I analogs: effects on insulin secretion and adenosine 3',5'-monophosphate formation. Endocrinology. 1990 Apr; 126(4):2164-8.
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest. 1987 Feb; 79(2):616-9.
The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes. 1999 Mar; 48(3):507-13.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.